WASHINGTON & ROCHESTER, Minn. & NIJMEGEN, Netherlands & DUISBURG, Germany--(BUSINESS WIRE)--
Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally
Extremely low-cost, pain-free system could be a game changer
No more lancets, glucometers
Real-time cloud-based readings deliverable to caregivers and providers anywhere instantly via NFC cell phones
Opportunity to improve diabetes outcomes worldwide
Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide.
Help employers find you! Check out all the jobs and post your resume.
Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally
Extremely low-cost, pain-free system could be a game changer
No more lancets, glucometers
Real-time cloud-based readings deliverable to caregivers and providers anywhere instantly via NFC cell phones
Opportunity to improve diabetes outcomes worldwide
Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide.
Help employers find you! Check out all the jobs and post your resume.
